htmlOn October 18th news, recently, Purui Chunzheng Medical Technology Co., Ltd. completed a B round of financing of over 100 million yuan. This round of financing was led by Junlian Capital , followed by the old shareholder Kangjun Capital. This round of funds will be mainly used for overseas medical device resource construction, expansion of professional talent teams, strategic expansion in the medical device field, and upgrade and iteration of big data information platform.
Puri Puchun Certificate was established in June 2020. As a global SaaS+Data life science service provider, it is based on opening up the full process informationization of medical devices going overseas in the global market, helping medical devices, in vitro diagnosis, medical software AI and other products to provide full process consulting services for global market compliance access, covering device regulations consulting, local authorized representatives, product certification registration, overseas clinical trials, technical documents and system guidance, product testing and other full process services.
At present, Pure has more than 1,000 overseas registration/certification successful cases, including hundreds of British drug regulatory agencies (MHRA) certification, and Saudi , Thailand, Colombia and other countries medical registration and certification. Among these more than 1,000 cases, more than 50 are overseas clinical certification cases, including the successful cases of the US EUA emergency response, overseas clinical medical device certification cases, and the certified cases of the EU general whitelist.
founder of Pure Chun Certificate Meng Zhu said: "Prui Chun Certificate's original intention is to help Chinese medical device companies go overseas and expand overseas clinical resources. Pure Chun Certificate currently has 10 clinical centers to build a station-based, full-chain service ecosystem. Through accumulation of experience in the fields of computer technology and big data, we use new generation information technology to empower medical innovation, and are committed to establishing a standardized and digital medical device overseas system. Pure Chun Certificate's professional multi-national medical device market access consulting services and high-quality overseas clinical resources can meet the needs of domestic medical device companies for cross-border registration CROs in multiple countries and categories. The company's development cannot be separated from new and old shareholders and The strong support of customer partners, Purui Chun Certificate’s global regulatory intelligent platform will continue to complete iteration and upgrade after this round of financing, providing data services such as corporate product trade analysis, overseas dealer network, clinical trend research, etc., to help medical device companies go overseas. "Dai Yiren, partner of Kangjun Capital, said: "Prui Chun Certificate improves the efficiency and standardization of medical device registration and clinical services through data technology, and is committed to creating a registration needs for multiple countries and multiple categories, covering a series of business such as R&D registration strategies, registration declarations, overseas clinical, and commercial data, and has a certain influence in the field of cross-border registration of medical devices. Kangjun Capital is Purui Chun Certificate The A-round investors have witnessed the rapid growth of Pure Chunzheng in business scale, overseas resources, talent echelons, etc. In the future, they hope to continue to work with Pure Chunzheng to provide high-quality services for cross-border registration and commercialization of medical device products."
